Search

You searched for "ophthalmoscope"

2346 results found

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | Retina / Uvea / Vitreous
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat

1 April 2017 | | Retina / Uvea / Vitreous
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...

Myopia management

1 December 2022 | | Ophthalmology
With the growing prevalence of myopia at epidemic levels in some countries and increasing number of research publications on myopia control, there is a lot of controversy regarding the management of myopia. As none of them are at present available...

DMEK vs. UT-DSAEK: has the debate been finally concluded?

1 October 2021 | | Ophthalmology, Cornea / External Eye Disease
In recent years the surgical treatment of corneal endothelial dystrophy has progressed tremendously. Descemet’s membrane endothelial keratoplasty (DMEK) is the newest iteration in the line of rapid surgical advances that has taken place. However, the previously accepted gold standard prior...

Pharmacopoeia of the Royal Infirmary of Edinburgh

4 February 2021 | | Ophthalmology
The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....

A tale of two membranes

1 February 2016 | | Retina / Uvea / Vitreous
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...

Simulation in ophthalmology: a pedagogic viewpoint

1 April 2017 | | Cataract and Refractive
The advent of simulation technology has enhanced modern medical training. The first utilisation of simulation was in 1929 where Edward Link used this concept to develop a mechanical flight simulator [1]. Industries such as aviation, nuclear power and the military...

The Eyes Have It and World Eye Health Day - A Q&A with Marsha de Cordova

15 December 2023 | TEHI, WEHD, Politics, eye health, report, change, sight loss
Westminster Eye Health Day is the flagship parliamentary event of The Eyes have It, a partnership of Roche, Macular Society, Fight for Sight, The Royal College of Ophthalmologists, Association of Optometrists and RNIB and has returned for its third year, sponsored by Marsha de Cordova MP.

Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin

3 June 2024 | | Retina / Uvea / Vitreous
Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...

Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa

1 June 2022 | | Ophthalmology, Cornea / External Eye Disease
Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...

The David J Apple International Laboratory for Ocular Pathology – a legacy of pioneering IOL research

1 October 2016 | | Cataract and Refractive
David Apple and Gerd Auffarth. The Apple Lab at the David J Apple Center for Vision Research in Heidelberg is a thriving international laboratory for research into intraocular devices. The lab continues the work of David J Apple, a world-renowned...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | Retina / Uvea / Vitreous
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...